Context.—Colorectal cancer, the most lethal long-term complication of chronic inflammatory
bowel disease (IBD), is the culmination of a complex sequence of molecular and histologic …

Context.—Inflammatory bowel disease (IBD) is a long-standing chronic active inflammatory
process in the bowel with increased risk for the development of colorectal carcinoma …

The clinical management of patients with dysplasia in chronic inflammatory bowel disease
(IBD) is currently guided by Riddell et al.'s grading system (negative, indefinite, low grade …

The development of colorectal cancer is the most serious long-term problem faced by
patients with extensive ulcerative colitis and Crohn's colitis, with an incidence 20-fold higher …

The risk of developing dysplasia leading to colorectal cancer (CRC) is increased in both
ulcerative colitis and Crohn's disease. The prognosis of CRC may be poorer in patients with …

Colorectal cancer is the most serious complication of chronic inflammatory bowel disease. It
is generally accepted that dysplasia in most cases precedes the development of colorectal …

Surveillance for neoplasia in colitis is the most challenging diagnostic colonoscopic
procedure. The detection and treatment of colorectal dysplasia in inflammatory bowel …

In ulcerative colitis (UC) and Crohn's disease (CD), there is abundant evi-dence to support
the theory that cancer develops through an inflammation-dysplasia-carcinoma sequence [1 …

Reduction of mortality from colorectal cancer is a prime goal in the clinical management of
patients with extensive, longstanding ulcerative colitis and colonic Crohn's disease. The …

Both ulcerative colitis and Crohn's disease carry an increased risk of developing colorectal
cancer. Established risk factors for cancer among patients with inflammatory bowel disease …